Cargando…
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1
Autores principales: | Wang, Jiyan, Qiao, Yaya, Sun, Mingming, Sun, Huanran, Xie, Fei, Chang, Hongkai, Wang, Yingzhi, Song, Jiaqi, Lai, Sizhen, Yang, Chenxin, Li, Xichuan, Liu, Shuangping, Zhao, Xuanzhu, Ni, Kemin, Meng, Kewei, Zhang, Shuai, Shan, Changliang, Zhang, Chunze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926902/ https://www.ncbi.nlm.nih.gov/pubmed/35297218 http://dx.doi.org/10.1002/ctm2.772 |
Ejemplares similares
-
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism
por: Sun, Mingming, et al.
Publicado: (2023) -
PIKE-A Modulates Mitochondrial Metabolism through Increasing SDHA Expression Mediated by STAT3/FTO Axis
por: Sun, Mingming, et al.
Publicado: (2022) -
Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022) -
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022) -
The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer
por: Wang, Jiyan, et al.
Publicado: (2023)